A groundbreaking development in the field of neurology could offer hope to millions of Alzheimer's patients worldwide. A newly approved drug, Cobenfy, initially designed to treat schizophrenia, is now being explored for its potential to alleviate the debilitating symptoms of Alzheimer's-related psychosis. The Science Behind Cobenfy Cobenfy, a combination of Xanomeline and … [Read more...] about Newly Approved Schizophrenia Drug Could Eventually Treat Alzeimer’s-Related Psychosis